Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats

Abd El-Gawad, 2001, Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain, Pharmacol. Res., 43, 257, 10.1006/phrs.2000.0781

Annapurna, 2009, Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats, J. Pharm. Pharmacol., 61, 1365, 10.1211/jpp.61.10.0014

Awan, 1996, Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure, Am. Heart J., 131, 177, 10.1016/S0002-8703(96)90067-8

Beutler, 1987, Cachectin: more than a tumor necrosis factor, N. Engl. J. Med., 316, 379, 10.1056/NEJM198702123160705

Bien, 2007, The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy, Cancer Res., 67, 10428, 10.1158/0008-5472.CAN-07-1344

Cao, 1997, Antioxidant and prooxidant behavior of flavonoids: structure–activity relationships, Free Radic. Biol. Med., 22, 749, 10.1016/S0891-5849(96)00351-6

Carretero, 2005, Novel mechanism of action of ACE and its inhibitors, Am. J. Physiol. Heart Circ. Physiol., 289, H1796, 10.1152/ajpheart.00781.2005

Corna, 2004, Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritin, J. Biol. Chem., 279, 13738, 10.1074/jbc.M310106200

Du, 2010, Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice, Int. Immunopharmacol., 10, 819, 10.1016/j.intimp.2010.04.018

Duvnjak, 2009, The metabolic syndrome – an ongoing story, J. Physiol. Pharmacol., 60, 19

Fadillioglu, 2003, Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats, Pharmacol. Res., 47, 317, 10.1016/S1043-6618(03)00010-0

Fouad, 2011, Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity, Arch. Pharm. Res., 34, 821, 10.1007/s12272-011-0516-2

Glasser, 2002, Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites, Phytomedicine, 9, 33, 10.1078/0944-7113-00080

Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ. Res., 74, 1141, 10.1161/01.RES.74.6.1141

Hahn, 1994, Activation of human peripheral monocytes by angiotensin II, FEBS Lett., 347, 178, 10.1016/0014-5793(94)00531-1

Haleagrahara, 2009, Flavonoid quercetin protects against swimming stress-induced changes in oxidative biomarkers in the hypothalamus of rats, Eur. J. Pharmacol., 621, 46, 10.1016/j.ejphar.2009.08.030

Hertog, 1996, Fruit and vegetable consumption and cancer mortality in the Caerphilly Study, Cancer Epidemiol. Biomarkers Prev., 5, 673

Kalender, 2011, Protective effects of catechin and quercetin on antioxidant status, lipid peroxidation and testis-histoarchitecture induced by chlorpyrifos in male rats, Environ. Toxicol. Pharmacol., 33, 141, 10.1016/j.etap.2011.12.008

Kawabata, 2001, Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts, Hypertens. Res., 24, 403, 10.1291/hypres.24.403

Keidar, 1997, The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice, Biochem. Biophys. Res. Commun., 236, 622, 10.1006/bbrc.1997.6844

Li, 2013, The effect of quercetin on doxorubicin cytotoxicity in human breast cancer cells, Anticancer Agents Med. Chem., 13, 352, 10.2174/1871520611313020020

Loizzo, 2007, Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae), Phytother. Res., 21, 32, 10.1002/ptr.2008

Lovric-Bencic, 2004, Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse, J. Pharmacol. Sci., 95, 19, 10.1254/jphs.95.19

Meier, 1989, Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha, Biochem. J., 263, 539, 10.1042/bj2630539

Morin, 1977, Creatine kinase: re-examination of optimum reaction conditions, Clin. Chem., 23, 1569, 10.1093/clinchem/23.9.1569

Muthukumaran, 2008, Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats, Toxicology, 243, 207, 10.1016/j.tox.2007.10.006

Nishikimi, 1972, The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen, Biochem. Biophys. Res. Commun., 46, 849, 10.1016/S0006-291X(72)80218-3

Rogler, 1998, Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa, Gastroenterology, 115, 357, 10.1016/S0016-5085(98)70202-1

Saad, 2001, The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats, Pharmacol. Res., 43, 211, 10.1006/phrs.2000.0769

Sano, 2001, ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts, Circ. Res., 89, 661, 10.1161/hh2001.098873

Schieffer, 1994, Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat, Circulation, 89, 2273, 10.1161/01.CIR.89.5.2273

Sestili, 1998, Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism, Free Radic. Biol. Med., 25, 196, 10.1016/S0891-5849(98)00040-9

Sharma, 2001, Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats, Mol. Cell. Biochem., 225, 75, 10.1023/A:1012220908636

Shen, 2008, The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells, Int. J. Hyperthermia, 24, 151, 10.1080/02656730701843109

Siveski-Iliskovic, 1994, Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats, Circulation, 89, 2829, 10.1161/01.CIR.89.6.2829

Staedler, 2011, Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells, Cancer Chemother. Pharmacol., 68, 1161, 10.1007/s00280-011-1596-x

Toko, 2002, Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy, Hypertens. Res., 25, 597, 10.1291/hypres.25.597

Torre-Amione, 1996, Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD), J. Am. Coll. Cardiol., 27, 1201, 10.1016/0735-1097(95)00589-7

Tsikas, 2007, Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the l-arginine/nitric oxide area of research, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 851, 51, 10.1016/j.jchromb.2006.07.054

Upadhyay, 2010, The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl l-glutamate)-b-hyaluronan polymersomes, Biomaterials, 31, 2882, 10.1016/j.biomaterials.2009.12.043

Wang, 2012, Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl, PLoS ONE, 7, e51764, 10.1371/journal.pone.0051764

Wang, 2009, Effects of recombinant human relaxin upon proliferation of cardiac fibroblast and synthesis of collagen under high glucose condition, J. Endocrinol. Invest., 32, 242, 10.1007/BF03346460

Widdop, 2003, Angiotensin AT2 receptors: cardiovascular hope or hype?, Br. J. Pharmacol., 140, 809, 10.1038/sj.bjp.0705448

Yogeeta, 2006, Synergistic interactions of ferulic acid with ascorbic acid: its cardioprotective role during isoproterenol induced myocardial infarction in rats, Mol. Cell. Biochem., 283, 139, 10.1007/s11010-006-2494-0